Dianne Feinstein on Drugs Democratic Sr Senator (CA)

Voted NO on increasing penalties for drug offenses.

Voted NO on spending international development funds on drug control.

Federal grants to Indian tribes to fight methamphetamine.

OFFICIAL CONGRESSIONAL SUMMARY: A bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to clarify that territories and Indian tribes are eligible to receive grants for confronting the use of methamphetamine.

EXCERPTS OF BILL: Amends the Omnibus Crime Control and Safe Streets Act of 1968 to include territories and Indian tribes as eligible grant recipients (or reaffirm such eligibility) under the programs to:

1. address the manufacture, sale, and use of methamphetamine;
2. aid children in homes in which methamphetamine or other drugs are unlawfully manufactured, distributed, dispensed, or used; and
3. address methamphetamine use by pregnant and parenting women offenders.

LEGISLATIVE OUTCOME:Passed/agreed to in Senate, by Unanimous Consent.

Enhance interdiction by criminalizing unflagged submarines.

Legislative Summary:A bill to enhance drug trafficking interdiction by creating a Federal felony for operating or embarking in a submersible or semi-submersible vessel without nationality and on an international voyage.

Cogressional Findings:
• Congress finds that operating or embarking in a submersible or semi-submersible vessel without nationality and on an international voyage is a serious international problem, facilitates transnational crime, including drug trafficking, and terrorism, and presents a specific threat to the safety of maritime navigation and the security of the United States.
• Whoever knowingly operates in any submersible vessel that is without nationality and that is navigating waters beyond the outer limit of the territorial sea of a single country, with the intent to evade detection, shall be punished as prescribed
• House version is H.R.6295; related Senate bill S.3198.

Rated C- by NORML, indicating a "hard-on-drugs" stance.

OnTheIssues.org interprets the 2016 NORML scores as follows:

• C-/D/F: "hard-on-drugs" stance (approx. 243 members)
• C: mixed record on drug reform (approx. 45 members)
• A/B: pro-drug-reform stance (approx. 293 members)

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Criminalize imports of opioid precursors.

Excerpts from Letter from 17 Senators to the President of the European Commission We write to request designating NPP and ANPP, which are precursor chemicals of the synthetic opioid fentanyl, as Table I substances under the 1988 UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. NPP and ANPP are [legal under EU law but] already controlled in the U.S. under the Controlled Substances Act. However, without collective international action it will be difficult to control NPP and ANPP, and will frustrate efforts to curb manufacturing and trafficking of illicit fentanyl.

Opposing argument: (ACLU, "Against Drug Prohibition"): People in almost all cultures, in every era, have used psychoactive drugs. A "drug free America" is not a realistic goal, and by criminally banning psychoactive drugs the government has ceded control of potentially dangerous substances to criminals. Instead of trying to stamp out drug use, our government should focus on reducing drug abuse and prohibition-generated crime. This requires a fundamental change in public policy: repeal of criminal prohibition and the creation of a reasonable regulatory system.

Opposing argument: (Cato Institute, "Do Restrictions Reduce Opioid Poisonings?", by Jeffrey Miron): Prescription Drug Monitoring Programs (PDMPs), which record a patient's opioid prescribing history, when required as "must access," PDMPs significantly reduce misuse in Medicare Part D. But there is no statistically significant effect on opioid poisoning incidents. How is this possible? The simplest explanation is that, despite all the hype, prescription opioids are not that dangerous, even in heavy doses, when used under medical supervision. Instead, most poisonings reflect use of diverted prescription opioids, or black market opioids, which may be adulterated. Under this interpretation, restrictions on opioid prescribing might even increase opioid poisonings.

Require chemical resellers to certify against meth use.

Sen. FEINSTEIN: This act is designed to address problems that the Drug Enforcement Administration, DEA, has identified in the implementation of the Combat Methamphetamine Epidemic Act of 2005. The bill that I introduce today would:

• clarify that all retailers, including mail order retailers, who sell products that contain chemicals often used to make methamphetamine--like ephedrine, pseudoepedrine and phenylpropanolamine--must self-certify that they have trained their personnel and will comply with the Combat Meth Act's requirements;
• require distributors to sell these products only to retailers who have certified that they will comply with the law;
• require the DEA to publish the list of all retailers who have filed self-certifications, on the DEA's website;
• and clarify that any retailer who negligently fails to file self-certification as required, may be subject to civil fines and penalties.

This is a common-sense bill, designed to strengthen the implementation of the Combat Methamphetamine Epidemic Act. This bill would create incentives to ensure that the self-certification process of the law is made both effective and enforceable. I urge my colleagues to support this legislation.